Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

Applications for changes in the OPCS-4.11 classification in England accepted till December 1, 2024

In September 2023, NHS England defined the roadmap and key dates for the next version of the OPCS-4 nomenclature of procedures, which is updated every three years. 

The release of OPCS-4.11 is scheduled for April 1, 2026. The applications for changes can be submitted via the Request Submission Portal no later than December 1, 2024, to be implemented in the OPCS-4.11 version. 

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial. 

Tags
UK
Reimbursement application
Procedural classification

The latest related news

12
Dec 2024

The Innovation Ecosystem Programme report was published in England

On November 28, 2024, NHS England published a report summarising the Innovation Ecosystem Programme’s (IEP) findings and recommendations for the next steps. The IEP aimed to foster collaboration between the NHS and key stakeholders (industry, academia, and regulators) to streamline healthcare innovation. Recommendations are summarised in four areas: a) setting the direction, b) structures and tools for delivery, c) people, skills, and capabilities, and d) acceleration.
Read more
12
Nov 2024

Med Tech-related health technology assessments from NIHR in October 2024

In October 2024, the National Institute for Health and Care Research (NIHR) in England released seven Med Tech-related assessments in its HTA Journal, which concerned the Genedrive kit, timing of stoma closure in neonates, interventions in perceptual disorders after stroke, revascularisation strategy for chronic limb ischemia, MRI software and cognitive fusion biopsies in prostate cancer, transperineal prostate biopsy devices, and ultraviolet therapy in severe eczema. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs NICE guidance.
Read more
07
Nov 2024

Med Tech-related technology assessments from NICE in October 2024

In October 2024, the National Institute for Health and Care Excellence (NICE) published two new Diagnostics Guidance concerning heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices and digital technologies for assessing attention deficit hyperactivity disorder.
Read more